Camilla Avagliano
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Camilla Avagliano has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- Andrea de Bartolomeis
Unit for Treatment-Resistant Psychoses, Section of Psychiatry, Department of Neuroscience, Reproductive Sciences and Dentistry - University of Naples "Federico II", Naples, Italy; UNESCO Staff Chair on Health Education and Sustainable Development, University "Federico II", Naples, Italy
6 shared publications Benedetta Altavilla
Unit of Treatment Resistant Psychosis and Laboratory of Molecular and Translational Psychiatry, Section of Psychiatry, Department of Neuroscience, Reproductive Science and Odontostomatology, University School of Medicine "Federico II", Naples, Italy
4 shared publications- Annarita Barone
Department of Neuroscience, Reproductive Sciences and Dentistry, University of Naples Federico II, Naples, Italy
3 shared publications - Danilo Notar Francesco
Unit of Treatment Resistant Psychosis and Laboratory of Molecular and Translational Psychiatry, Section of Psychiatry, Department of Neuroscience, Reproductive Science and Odontostomatology, University School of Medicine "Federico II", Naples, Italy
3 shared publications Felice Iasevoli
Section of Psychiatry, Unit on Treatment Resistant Psychosis, and Laboratory of Molecular and Translational Psychiatry, Department of Neuroscience, University School of Medicine Federico II, Via Pansini 5 Edificio n.18 3rd floor, Naples 80131, Italy
3 shared publications- Luigi D'AMbrosio
Laboratory of Molecular and Translational Psychiatry, Unit of Treatment Resistant Psychosis, Section of Psychiatry, Department of Neuroscience, Reproductive Science and Odontostomatology, University of Naples Federico II, 80131 Napoli, Italy
3 shared publications
Latest Publications
- 28 September 2022
- Published by Elsevier in Journal of Psychiatric Research
- Vol. 155, 572-578
Disorganization domain as a putative predictor of Treatment Resistant Schizophrenia (TRS) diagnosis: A machine learning approach
- 28 September 2022
- Published by Elsevier in Journal of Psychiatric Research
- Vol. 155, 572-578
Disorganization domain as a putative predictor of Treatment Resistant Schizophrenia (TRS) diagnosis: A machine learning approach
- Open Access
- 16 May 2021
- Published by Wiley in Early Intervention in Psychiatry
- Vol. 16 (4) , 352-362
Relationships between early age at onset of psychotic symptoms and treatment resistant schizophrenia
Aim: Early age at schizophrenia onset (EOS) has been associated with a worse clinical course, although previous studies reported substantial heterogeneity. Despite the relevance of the subject, the relationship between the age of onset and treatment resistant schizophrenia (TRS) is less clear.Methods: We screened 197 non‐affective psychotic patients. Of these, 99 suffered from schizophrenia and were putative TRS and were included in a prospective 4‐to‐8‐week trial to assess their response to antipsychotics. According to status (TRS/nonTRS) and age‐at‐onset (early: ≤18 years, EOS; adult: >18 years, adult onset schizophrenia [AOS]) patients were subdivided in EOS‐TRS, EOS‐nonTRS, AOS‐TRS, AOS‐nonTRS. Multiple clinical variables were measured and compared by analysis of covariance (ANCOVA), using age as a covariate. Two‐way analysis of variance (ANOVA) was used to assess whether significant differences were attributable to TRS status or age‐at‐onset.Results: The rate of TRS patients was significantly higher in EOS compared to AOS. At the ANCOVA, EOS‐TRS had significantly worse clinical, cognitive, and psychosocial outcomes compared to the other groups. Overall, EOS‐TRS were more impaired than EOS‐nonTRS, while significant differences with AOS‐TRS were less consistent, albeit appreciable. Two‐way ANOVA demonstrated that, in the majority of the investigated variables, the significant differences among groups were attributable to the TRS status effect rather than to age‐at‐onset or combined effects.Conclusions: These results suggest that refractoriness to antipsychotics may be strongly linked to the early onset of psychotic symptoms, possibly as a result of common neurobiology.
- 16 May 2021
- Published by Wiley in Early Intervention in Psychiatry
- Vol. 16 (4) , 352-362
Open AccessRelationships between early age at onset of psychotic symptoms and treatment resistant schizophrenia
Aim: Early age at schizophrenia onset (EOS) has been associated with a worse clinical course, although previous studies reported substantial heterogeneity. Despite the relevance of the subject, the relationship between the age of onset and treatment resistant schizophrenia (TRS) is less clear.Methods: We screened 197 non‐affective psychotic patients. Of these, 99 suffered from schizophrenia and were putative TRS and were included in a prospective 4‐to‐8‐week trial to assess their response to antipsychotics. According to status (TRS/nonTRS) and age‐at‐onset (early: ≤18 years, EOS; adult: >18 years, adult onset schizophrenia [AOS]) patients were subdivided in EOS‐TRS, EOS‐nonTRS, AOS‐TRS, AOS‐nonTRS. Multiple clinical variables were measured and compared by analysis of covariance (ANCOVA), using age as a covariate. Two‐way analysis of variance (ANOVA) was used to assess whether significant differences were attributable to TRS status or age‐at‐onset.Results: The rate of TRS patients was significantly higher in EOS compared to AOS. At the ANCOVA, EOS‐TRS had significantly worse clinical, cognitive, and psychosocial outcomes compared to the other groups. Overall, EOS‐TRS were more impaired than EOS‐nonTRS, while significant differences with AOS‐TRS were less consistent, albeit appreciable. Two‐way ANOVA demonstrated that, in the majority of the investigated variables, the significant differences among groups were attributable to the TRS status effect rather than to age‐at‐onset or combined effects.Conclusions: These results suggest that refractoriness to antipsychotics may be strongly linked to the early onset of psychotic symptoms, possibly as a result of common neurobiology.
- 1 November 2018
- Published by Elsevier in Psychiatry Research
- Vol. 269, 481-493
Evaluation of a few discrete clinical markers may predict categorization of actively symptomatic non-acute schizophrenia patients as treatment resistant or responders: A study by ROC curve analysis and multivariate analyses
- 1 November 2018
- Published by Elsevier in Psychiatry Research
- Vol. 269, 481-493
Evaluation of a few discrete clinical markers may predict categorization of actively symptomatic non-acute schizophrenia patients as treatment resistant or responders: A study by ROC curve analysis and multivariate analyses
- 1 February 2018
- Published by Elsevier in Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Vol. 81, 356-366
Treatment resistant schizophrenia and neurological soft signs may converge on the same pathology: Evidence from explanatory analysis on clinical, psychopathological, and cognitive variables
- 1 February 2018
- Published by Elsevier in Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Vol. 81, 356-366
Treatment resistant schizophrenia and neurological soft signs may converge on the same pathology: Evidence from explanatory analysis on clinical, psychopathological, and cognitive variables